The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Growth Overview

• Recent Growth: The opioid-induced constipation (OIC) treatment market has seen significant growth, increasing from $1.66 billion in 2023 to $1.78 billion in 2024, with a CAGR of 6.7%.
• Future Projections: Expected to grow to $2.31 billion by 2028 at a CAGR of 6.8%, driven by several factors.

Key Drivers in the Historic Period

• Expanding Geriatric Population: Older adults are more likely to use opioids, leading to higher instances of OIC.
• Personalized Treatments: Tailored OIC treatments have become more available, enhancing effectiveness.
• Effective OIC Drugs: Increased availability of drugs specifically targeting OIC.
• Prevalence of Opioid Use: Rising opioid prescriptions contribute to the need for OIC treatments.
• Gastrointestinal Disorders: A higher incidence of gastrointestinal issues boosts the demand for OIC therapies.

Drivers for Future Growth

• Accelerated Drug Approval: Faster approval processes for new drugs.
• Opioid Analgesic Prescriptions: Increasing use of opioids for pain management.
• R&D Expenditure: Significant investments in research and development for novel treatments.
• Development of Biologics: Advances in biologic treatments for OIC.

Read More On The Opioid-Induced Constipation Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Emerging Trends

• Patient Education: Increased efforts in educating patients about OIC and its treatments.
• Targeted Therapies: Development of therapies specifically targeting OIC mechanisms.
• Non-pharmacological interventions: Exploration of alternative treatments beyond medications.
• Biotechnology Innovations: Cutting-edge biotech solutions for managing OIC.
• Increased Investment: More financial resources directed towards OIC treatment advancements.

Rising Opioid Use for Pain Management

• Cancer and Non-Cancer Pain: Opioids are widely used for managing both cancer-related and non-cancer pain.
• Quality of Life: Effective OIC treatments improve patient comfort and adherence to pain management regimens without compromising pain relief.
• Statistics: According to the CDC, 20.9% of U.S. adults reported chronic pain in 2021, highlighting the need for OIC treatments.

Major Players in the Market

• Companies: Key players include Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Takeda Pharmaceutical Company Limited, and many others.

Developments in OIC Treatments

• Mu-Opioid Receptor Antagonists: Companies are focusing on these antagonists to manage OIC effectively.
• Notable Approval: In December 2021, Shionogi & Co. Ltd. received approval for Symproic (naldemedine) in Taiwan, expanding treatment options.

Grünenthal and Kyowa Kirin Joint Venture

• Collaboration: In August 2023, Grünenthal GmbH and Kyowa Kirin International formed a joint venture to market pain management and OIC medications.
• Focus Areas: The collaboration includes a range of products, emphasizing OIC and pain management.

Market Segmentation

• By Drug Class: Includes laxatives, peripherally acting µ-opioid receptor antagonists, serotonin receptor agonists, and prostaglandin.
• By Type: Oral and parenteral treatments.
• By Distribution Channel: Hospital pharmacies, online pharmacies, and retail pharmacies.

Regional Insights

• North America: Largest market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

The opioid-induced constipation treatment market is poised for continued growth, driven by increasing opioid use, advancements in treatment options, and significant investments in R&D. With major players innovating and forming strategic collaborations, the market is set to expand, offering improved solutions for patients suffering from OIC.

Request for A Sample Of The Global Opioid-Induced Constipation Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15881&type=smp